A recent retrospective study found no significant differences in terms of clinical response following the switch (56)
Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
At high doses, sugar alcohols can lead to IBS-type symptoms in both individuals with IBS and healthy subjects
Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin
EgerodKLEngelstoftMSGrunddalKVNohrMKSecherASakataIet al